The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C

著者: Dai, Chia‐Yen, Huang, Jee‐Fu, Hsieh, Ming‐Yen, Lee, Li‐Po, Ho, Chi‐Kung, Chuang, Wan‐Long, Yu, Ming‐Lung
出版事項 2007

Links between triglyceride levels, hepatitis C virus infection and diabetes

著者: Dai, Chia‐Yen, Huang, Jee‐Fu, Hsieh, Ming‐Yen, Lee, Li‐Po, Hou, Nai‐Jen, Yu, Ming‐Lung, Chuang, Wan‐Long
出版事項 2007

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

著者: Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
出版事項 2005

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin

著者: Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Hou, Nei-Jen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Yu, Ming-Lung
出版年 World J Gastroenterol (2005)

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

著者: Yu, Ming‐Lung, Dai, Chia‐Yen, Huang, Jee‐Fu, Hou, Nai‐Jen, Lee, Li‐Po, Hsieh, Ming‐Yen, Chiu, Chang‐Fu, Lin, Zu‐Yau, Chen, Shinn‐Cherng, Hsieh, Ming‐Yuh, Wang, Liang‐Yen, Chang, Wen‐Yu
出版事項 2007

The incidence and risks of liver biopsy in non‐cirrhotic patients: An evaluation of 3806 biopsies

著者: Huang, Jee‐Fu, Hsieh, Ming‐Yen, Dai, Chia‐Yen, Hou, Nai‐Jen, Lee, Li‐Po, Lin, Zu‐Yau, Chen, Shinn‐Chern, Wang, Liang‐Yen, Hsieh, Ming‐Yuh, Chang, Wen‐Yu, Yu, Ming‐Lung, Chuang, Wan‐Long
出版事項 2007